Québec marks the inauguration of the Green Cross Biotherapeutics facilities in Montréal

Montréal, October 30, 2017 – Green Cross Biotherapeutics today inaugurated its new plasma fractionation plant in Technoparc Montréal, a $400-million project that will create more than 200 jobs. In 2014, the Québec government granted $25 million, which included a non-repayable financial contribution of $8 million and a $17-million loan in support of this project.


Read the full article published by Investissement Quebec.